Magnetothermal nanoparticle technology alleviates parkinsonian symptoms in mice

QR Code

Magnetothermal nanoparticle technology alleviates parkinsonian symptoms in mice

Enregistré dans:

Détails bibliographiques
Auteur principal:	Sarah Hescham
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Accès en ligne:	https://doaj.org/article/4f91449dfa744f7b87b66b617a6a4e4d
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Magnetothermal nanoparticle technology alleviates parkinsonian-like symptoms in mice
par: Sarah-Anna Hescham, et autres
Publié: (2021)

Wireless magnetomechanical and magnetothermal neuromodulation with magnetite nandiscs
par: Danijela Gregurec, et autres
Publié: (2021)

Wireless deep brain stimulation in freely moving mice with nonresonant powering of magnetoelectric nanoparticles
par: Ali Jahanshahi, et autres
Publié: (2021)

Connectome-targeted neuromodulation across symptoms and disorders
par: Shan Siddiqi
Publié: (2021)

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
par: Sarah Huffman, et autres
Publié: (2021)

At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue
par: Christopher Austelle, et autres
Publié: (2021)

Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
par: Marco Mauri, et autres
Publié: (2008)

Structure and stability of symptoms in first episode psychosis: a longitudinal network approach
par: Siân Lowri Griffiths, et autres
Publié: (2021)

EEG microstates changes in schizophrenia patients with negative symptoms after accelerated repetitive transcranial magnetic stimulation
par: Tomas Sverak, et autres
Publié: (2021)

Baseline symptom profile does not predict early response to electroconvulsive therapy (ECT) in major depressive disorder (MDD)
par: Bijan Zarrabi, et autres
Publié: (2021)

App-based ecological momentary assessment and symptom-adaptive scheduling of TMS maintenance treatments to prevent depressive episode recurrence
par: Linda Carpenter, et autres
Publié: (2021)

Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly
par: Zeyan Peng, et autres
Publié: (2021)

Chemo/optogenetic stimulation and photometry monitoring of neuron activity in mice
par: Yunlei Yang
Publié: (2021)

A comparison of symptom-specific resting state functional connectivity biomarkers of 10 Hz and iTBS-rTMS in treatment-resistant depression
par: Katharine Dunlop, et autres
Publié: (2021)

Corrigendum: Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly
par: Zeyan Peng, et autres
Publié: (2021)

Hindbrain TMS in mice elicits structural and functional changes related to improvements in processing speed
par: M. Windy McNerney, et autres
Publié: (2021)

Focal stimulation of movement related cortical potentials in mice using a novel TMS circuit design
par: Haley Strong, et autres
Publié: (2021)

Correction to: APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline
par: Wenting Fang, et autres
Publié: (2021)

Transauricular vagal nerve stimulation at 40Hz attenuates hippocampal amyloid load in 6-month-old APP/PS mice
par: Yutian Yu, et autres
Publié: (2021)

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761&reg;. Findings from a randomized controlled trial
par: Bachinskaya N, et autres
Publié: (2011)

The “RF-EEG Cap”: a technological solution for high sensitivity whole-head concurrent TMS/EEG/fMRI experiments at 3T
par: Lucia Navarro de Lara, et autres
Publié: (2021)

Dopaminergic Modulation of Spectral and Spatial Characteristics of Parkinsonian Subthalamic Nucleus Beta Bursts
par: Matthias Sure, et autres
Publié: (2021)

Repetitive transcranial magnetic stimulation (rTMS) for catatonia– a case report
par: Christiane Licht, et autres
Publié: (2021)

Integrating electrical field maps and alcohol cue-reactivity patterns to improve TMS treatment outcome in Alcohol Use Disorder: a retrospective analysis
par: Daniel McCalley, et autres
Publié: (2021)

Increasing the number of daily stimulation sessions administered during taVNS-paired bottle feeding speeds response time in newborns with feeding difficulty
par: Lauren Adams, et autres
Publié: (2021)

Does Synchronizing TMS pulses with EEG alpha Phase improve the Antidepressant Efficacy of Prefrontal TMS?
par: Sarah Huffman, et autres
Publié: (2021)

Outcomes from University of Minnesota Clinical rTMS Clinic for resistant depression: naturalistic data on suicidal ideation
par: A.Irem Sonmez, et autres
Publié: (2021)

Hippocampal potentials evoked by network-targeted stimulation vary by theta phase
par: Sarah M. Lurie, et autres
Publié: (2021)

Covid effects on clinical outcomes of TMS treatment: a naturalistic study
par: A.IREM SONMEZ, et autres
Publié: (2021)

Theta synchronized closed-loop stimulation increases hippocampal excitability in humans
par: James Kragel, et autres
Publié: (2021)

Six weeks of daily prefrontal closed-loop repetitive transcranial magnetic stimulation (rTMS) produces progressive EEG-α phase entrainment in depressed adults
par: Josef Faller, et autres
Publié: (2021)

Can passive measurement of physiological distress help better predict suicidal thinking?
par: Evan M. Kleiman, et autres
Publié: (2021)

Widespread attenuating changes in brain connectivity associated with the general factor of psychopathology in 9- and 10-year olds
par: Chandra Sripada, et autres
Publié: (2021)

Biofeedback as an intervention for persistent post-concussive symptoms: A randomized feasibility trial
par: Marquise M Bonn, et autres
Publié: (2021)

Noradrenergic symptom cluster in depression
par: Montgomery S, et autres
Publié: (2011)

Neuropsychiatric symptoms and celiac disease
par: Urban-Kowalczyk M, et autres
Publié: (2014)

Behavioral symptoms related to cognitive impairment
par: Dillon C, et autres
Publié: (2013)

Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients
par: Klaus Oliver Schubert, et autres
Publié: (2021)

Update on the management of symptoms in schizophrenia: focus on amisulpride
par: Ann M Mortimer
Publié: (2009)

The noradrenergic symptom cluster: clinical expression and neuropharmacology
par: Blier P, et autres
Publié: (2011)